Skip to main content
Erschienen in: BMC Infectious Diseases 7/2014

Open Access 01.12.2014 | Poster presentation

Buschke-Löwenstein tumor of the vulva in a patient with a history of squamous cell carcinoma of the cervix

verfasst von: Maria Isabela Sarbu, Ion Filimon Sarbu, Mircea Tampa, Vasile Benea, Ilinca Nicolae, Clara Matei, Teodor Poteca, Simona Roxana Georgescu

Erschienen in: BMC Infectious Diseases | Sonderheft 7/2014

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Background

Buschke-Löwenstein tumor (BLT) is a very rare sexually-transmitted disease associated with human papillomavirus (HPV) type 6 and 11, but rare cases of oncogenic HPV types including HPV 16 and HPV 18 were also reported. It is characterized by slow, locally invasive growth and clinically presents as exophytic masses with a cauliflower-like morphology. It usually occurs in uncircumcised men and location in sites other than the penis is very rare. It is a premalignant disorder with a low incidence of metastasis but with a considerable risk of malignant transformation to squamous cell carcinoma (SCC).

Case report

We report the case of a 51-year-old female patient who addressed our clinic for a large, exophytic, cauliflower-like tumor involving the vulva and the perineum. The patient had been diagnosed with invasive SCC of the cervix 13 years before and had undergone intracavitary brachytherapy with Iridium-192 with a total dose of 60 Gy at point A, followed by total hysterectomy with bilateral salpingo-oophorectomy and lymphadenectomy. She showed no recurrences to this day. At the same time as the cervical SCC diagnosis the patient presented small, papular, erythematous lesions located on the vulva and had been diagnosed with condyloma acuminata. She underwent several conservative therapies including podophyllin, cryotherapy and electrocoagulation as well as debulking and surgical treatment with several relapses over the years. The patient had not used any treatment for three years before returning to our department, during which time the lesions had slowly grown reaching giant dimensions.
Several biopsies were taken from the tumor and confirmed the clinical diagnosis of Buschke-Löwenstein tumor. The HIV testing turned out negative. The patient tested positive for HPV genotype 16. The other laboratory tests were within normal range.

Conclusion

Buschke-Löwenstein tumor can be associated with a high rate of recurrence and a risk of malignant transformation to invasive SCC, especially in patients with oncogenic types of HPV. The patient was sent to the general surgery department for excision and remains under the supervision of the dermatology and oncology department for rapid treatment of relapses and early detection of malignant transformation.
Written informed consent was obtained from the patient for publication of this Case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​4.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated.
Metadaten
Titel
Buschke-Löwenstein tumor of the vulva in a patient with a history of squamous cell carcinoma of the cervix
verfasst von
Maria Isabela Sarbu
Ion Filimon Sarbu
Mircea Tampa
Vasile Benea
Ilinca Nicolae
Clara Matei
Teodor Poteca
Simona Roxana Georgescu
Publikationsdatum
01.12.2014
Verlag
BioMed Central
Erschienen in
BMC Infectious Diseases / Ausgabe Sonderheft 7/2014
Elektronische ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-14-S7-P11

Weitere Artikel der Sonderheft 7/2014

BMC Infectious Diseases 7/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.